Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

BACKGROUND: In bladder cancer, up to 70% of patients will relapse after resection within 5 years, in which the mechanism underlying the recurrence remains largely unclear. METHODS: Quantitative real-time PCR, western blot and immunohistochemistry were conducted. The assays of tumor sphere formation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Junhao, Tian, Hu, Zhi, Xi, Xiao, Zhuoyu, Chen, Taoyi, Yuan, Haoyu, Chen, Qi, Chen, Mingkun, Yang, Jiankun, Zhou, Qizhao, Xue, Kangyi, Guo, Wenbin, Xia, Ming, Bao, Jiming, Yang, Cheng, Duan, Haifeng, Wang, Hongyi, Huang, Zhipeng, Zhu, Ting, Liu, Cundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665506/
https://www.ncbi.nlm.nih.gov/pubmed/34895217
http://dx.doi.org/10.1186/s12935-021-02315-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665506/
https://www.ncbi.nlm.nih.gov/pubmed/34895217
http://dx.doi.org/10.1186/s12935-021-02315-x

Ejemplares similares